Stocks and Investing Stocks and Investing
Wed, November 14, 2018
Tue, November 13, 2018

Liav Abraham Maintained (ABEO) at Strong Buy with Decreased Target to $700 on, Nov 13th, 2018


Published on 2024-10-26 10:37:32 - WOPRAI, Liav Abraham
  Print publication without navigation


Liav Abraham of Citigroup, Maintained "Abeona Therapeutics Inc." (ABEO) at Strong Buy with Decreased Target from $800 to $700 on, Nov 13th, 2018.

Liav, nor any peers, have made any analyst calls on ABEO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources